APTINYX INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 17 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-11-12: Reporting owner RIEDEL NORBERT G; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-09-20: Reporting owner RIEDEL NORBERT G; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-09-20: Reporting owner KHANNA ASHISH; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-06-20: Reporting owner HOMBACH ROBERT J.; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-11-12 | RIEDEL NORBERT G Director, Officer (CEO and President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −38,563 441,615 owned after | $2.59 exercise price | 2018-11-14 | |
| 2018-09-20 | RIEDEL NORBERT G Director, Officer (CEO and President) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +427,265 427,265 owned after | $27.43 exercise price | 2018-09-21 | |
| 2018-09-20 | KHANNA ASHISH Officer (CFO and CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $27.43 exercise price | 2018-09-21 | |
| 2018-06-20 holding as of filing | HOMBACH ROBERT J. Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $7.86 exercise price | 2018-06-20 | ||
| 2018-06-20 holding as of filing | Houck David Officer (Chief Development Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.16 exercise price | 2018-06-20 | ||
| 2018-06-20 holding as of filing | Houck David Officer (Chief Development Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $2.59 exercise price | 2018-06-20 | ||
| 2018-06-20 holding as of filing | Houck David Officer (Chief Development Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $5.13 exercise price | 2018-06-20 | ||
| 2018-06-20 holding as of filing | Houck David Officer (Chief Development Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $7.86 exercise price | 2018-06-20 | ||
| 2018-06-20 holding as of filing | MOSKAL JOSEPH R. Officer (Chief Scientific Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $2.59 exercise price | 2018-06-20 | ||
| 2018-06-20 holding as of filing | MOSKAL JOSEPH R. Officer (Chief Scientific Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $5.13 exercise price | 2018-06-20 | ||
| 2018-06-20 holding as of filing | Madsen Torsten M. Officer (Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $2.59 exercise price | 2018-06-20 | ||
| 2018-06-20 holding as of filing | Madsen Torsten M. Officer (Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $5.13 exercise price | 2018-06-20 | ||
| 2018-06-20 holding as of filing | KIDD ANDREW Officer (Chief Commercial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $5.13 exercise price | 2018-06-20 | ||
| 2018-06-20 holding as of filing | KHANNA ASHISH Officer (CFO and CBO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $2.59 exercise price | 2018-06-20 | ||
| 2018-06-20 holding as of filing | KHANNA ASHISH Officer (CFO and CBO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $5.13 exercise price | 2018-06-20 | ||
| 2018-06-20 holding as of filing | RIEDEL NORBERT G Director, Officer (CEO and President) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $2.59 exercise price | 2018-06-20 | ||
| 2018-06-20 holding as of filing | RIEDEL NORBERT G Director, Officer (CEO and President) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $5.13 exercise price | 2018-06-20 |